The Biotinidase Enzyme Activity Test is a vital diagnostic screening used primarily in newborns to measure the function of the biotinidase enzyme. This critical enzyme recycles biotin, vitamin B7, which is essential for normal metabolic processes.
The test identifies biotinidase deficiency, an inherited metabolic disorder. Without early detection and treatment, this condition can cause severe neurological damage, seizures, skin rashes, hearing loss, and developmental delays.
Conducted via a routine dried blood spot sample, the test enables prompt clinical intervention with daily biotin supplementation, effectively preventing all symptoms while ensuring healthy lifelong development and bright futures for affected children everywhere today.

An **Autism Screening Test Package** is a comprehensive diagnostic evaluation designed to identify developmental delays and behavioral traits associated with Autism Spectrum Disorder (ASD). Tailored for children, adolescents, or adults, this multi-disciplinary package typically combines standardized clinical screening tools, behavioral observations, developmental history assessments, and cognitive or communication evaluations.
By gathering structured insights from specialists—such as developmental pediatricians, psychologists, and speech therapists—the panel helps clarify social interaction patterns, sensory sensitivities, and repetitive behaviors. Early detection through a formal test package empowers families to access tailored therapies, educational support, and interventions during critical developmental windows.

The **Array Chrome test** (Chromosomal Microarray Analysis / Array CGH) is an advanced genetic diagnostic test used primarily to evaluate pediatric health and developmental conditions. By scanning an individual's entire genome sequence at high resolution, it identifies tiny, sub-microscopic chromosomal abnormalities—specifically copy number variations (CNVs) like microdeletions or microduplications of DNA—that traditional karyotyping misses.
Healthcare providers commonly order this blood test for children displaying developmental delays, intellectual disabilities, autism spectrum disorders, unexplained seizures, or congenital malformations. Identifying these subtle genetic changes helps clinicians pinpoint underlying medical causes, tailor personalized treatment plans, and provide informed genetic counseling to families.

An Egg White (Anda) Individual Food Allergen test is a specific blood test used to detect an allergic sensitivity to proteins found in egg whites. Egg allergy is one of the most common food allergies, particularly in children. While both the yolk and the white contain proteins, the white is typically the primary trigger for allergic reactions.

The test measures the level of specific IgE antibodies produced by the immune system in response to egg white exposure. A positive result helps clinicians diagnose the allergy, allowing individuals to manage symptoms by avoiding egg-containing products and preventing potential reactions like hives, digestive distress, or anaphylaxis.

An AFB-Xpert Panel (M.Tb Detection & Rifampicin Resistance) by CBNAAT for pulmonary samples is a highly efficient, automated molecular test. It serves as the frontline tool for rapidly diagnosing Tuberculosis (TB) in the lungs and checking if the bacteria are resistant to one of the most powerful first-line TB medications, Rifampicin.

Unlike extra-pulmonary testing, which deals with fluids and tissues from other organs, pulmonary testing specifically evaluates secretions from the respiratory tract.

1. What does the name mean?
AFB: Acid-Fast Bacilli (the class of bacteria to which Mycobacterium tuberculosis belongs).

CBNAAT: Cartridge-Based Nucleic Acid Amplification Test (commonly known as the GeneXpert test). It uses PCR technology to multiply and detect the DNA of the TB bacteria.

Pulmonary samples: Samples originating from the lungs and respiratory airways.

2. Common Pulmonary Sample Types
Because pulmonary TB directly affects the lungs, the sample types are respiratory secretions:

Sputum (Spontaneous): The thick mucus coughed up deeply from the lungs. This is the most common sample type.

Induced Sputum: If a patient cannot cough up sputum naturally, they inhale a sterile saline mist to help loosen secretions.

Bronchoalveolar Lavage (BAL): Fluid collected during a bronchoscopy, where a doctor passes a small scope into the lungs and flushes the area with saline. This is often used for complex or hard-to-diagnose cases.

Gastric Aspirate/Lavage: Commonly used in young children who cannot expectorate (spit out) sputum and instead swallow their respiratory secretions overnight.

25 OH Vitamin D blood test, often called the Vitamin D Test, is the most accurate way to measure the body's vitamin D status.
Purpose Assess Vitamin D Status: Measures the main circulating form of Vitamin D (Calcidiol), reflecting total intake from sun exposure, diet, and supplements.
Diagnose Deficiency or Insufficiency: Used to determine if levels are too low, which can lead to bone disorders like rickets in children and osteomalacia/osteoporosis in adults.
Monitor Treatment: Evaluates the effectiveness of vitamin D supplementation in patients with diagnosed deficiency.
Investigate Abnormal Calcium/Phosphate: Used in the workup for conditions affecting calcium metabolism, bone health, or parathyroid function.

This refers to the loss of part or all of chromosome 7's long arm (q-arm), or the entire chromosome, which is a significant cytogenetic abnormality in Myelodysplastic Syndromes (MDS) and often associated with a poorer prognosis.
Genetic Abnormality:
Monosomy 7 (-7): Complete loss of one copy of chromosome 7. This is the most common and generally carries the worst prognosis among 7q abnormalities.
Deletion of 7q : Partial loss of the long arm of chromosome 7. The commonly deleted region (CDR) is typically located at 7q22-7q32.
Association with Other Conditions: Can occur as a sole abnormality in de novo MDS.
Frequently seen in therapy-related MDS (t-MDS) and therapy-related Acute Myeloid Leukemia (t-AML), particularly after exposure to alkylating agents or topoisomerase II inhibitors.
Also associated with MDS in children, especially those with inherited bone marrow failure syndromes (e.g., Fanconi anemia, GATA2 deficiency).

Clinical Features: Often associated with bicytopenia or pancytopenia (low counts of two or more cell lines), including severe anemia, neutropenia, and thrombocytopenia.
Increased risk of infections due to neutropenia.
Higher risk of progression to Acute Myeloid Leukemia (AML) compared to other MDS subtypes, especially with monosomy 7.